CRISPR & the Future of Altering the Human Genome

Code: SL41812

Dates: November 11, 2021

Meets: 12:30 PM to 2:30 PM

Sessions: 1

Location: Creutzburg Center

Course Fee: $49.00

Sorry, we are no longer accepting registrations for this course. Please contact our office to find out if it will be rescheduled, or if alternative classes are available.

CRISPR (clustered regularly interspaced short palindromic repeats) allows scientists to make precise changes to the human genome. Jennifer Doudna and Emmanuelle Charpentier won the 2020 Nobel Prize in Chemistry for their pioneering work in this field. There have been highly publicized patent wars between leading American universities about who should control the use of CRISPR, and a Chinese scientist in 2018 announced he used CRISPR to modify the nuclear genome of a human being in a way that would be heritable. This controversial experiment resulted in the birth of three CRISPR edited babies who are to be immune from HIV infection that causes AIDS. CRISPR is a powerful technology that could prevent some diseases, but the consensus view of experts is that it is not technically ready for use and there are enormous ethical concerns about changing the genome of our species which is after all the result of millions of years of evolution. Explore this fascinating new technology. Lunch is included.
Fee: $49.00

Save $9.00 with a one of our membership programs. Contact our office for details.

Creutzburg Center

260 Gulph Creek Road
Radnor, PA 19087
Map & Directions

Kent Bottles

Dr. Kent Bottles teaches health policy and payment reform at The Thomas Jefferson University College of Population Health in Philadelphia and regularly consults and presents on population health, health care reform, digital medicine, and the future of the doctor patient relationship. He has been a Professor and Chair of academic medical school pathology departments, a Chief Medical Officer of a state-wide integrated delivery system, a President and CEO and DIO of an educational and research collaborative in Grand Rapids, Michigan, a President and CEO of an evidence-based medicine health care consortium in Minneapolis, and a President and Chief Knowledge Officer of a genomics bio-tech start-up company in Cambridge, Massachusetts. Dr. Bottles has received the following awards and honors: Phi Beta Kappa, The Rodney T. West Literary Achievement Award for the most important article on medical management in 2001 from the American College of Physician Executives, the Resident Teacher of the Year Award from the University of Iowa Department of Pathology, the UC San Francisco Class of 1991 Certificate of Distinction in Teaching for a Major Contribution, the UC San Francisco Class of 1990 Certificate of Distinction in Teaching for a Stimulating Lecture Series, and the Henry J. Kaiser Award for Excellence in Teaching at UC San Francisco for Basic Science.


Email Information to Friend Print